JP2024150674A5 - - Google Patents

Download PDF

Info

Publication number
JP2024150674A5
JP2024150674A5 JP2024119250A JP2024119250A JP2024150674A5 JP 2024150674 A5 JP2024150674 A5 JP 2024150674A5 JP 2024119250 A JP2024119250 A JP 2024119250A JP 2024119250 A JP2024119250 A JP 2024119250A JP 2024150674 A5 JP2024150674 A5 JP 2024150674A5
Authority
JP
Japan
Prior art keywords
amino acid
variable region
seq
acid sequence
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024119250A
Other languages
English (en)
Japanese (ja)
Other versions
JP7818042B2 (ja
JP2024150674A (ja
Filing date
Publication date
Priority claimed from JP2021510094A external-priority patent/JP2021534220A/ja
Application filed filed Critical
Publication of JP2024150674A publication Critical patent/JP2024150674A/ja
Publication of JP2024150674A5 publication Critical patent/JP2024150674A5/ja
Priority to JP2026018549A priority Critical patent/JP2026086616A/ja
Application granted granted Critical
Publication of JP7818042B2 publication Critical patent/JP7818042B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024119250A 2018-08-22 2024-07-25 抗her2ポリペプチド及びそれらの使用の方法 Active JP7818042B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026018549A JP2026086616A (ja) 2018-08-22 2026-02-06 抗her2ポリペプチド及びそれらの使用の方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862721505P 2018-08-22 2018-08-22
US62/721,505 2018-08-22
JP2021510094A JP2021534220A (ja) 2018-08-22 2019-08-22 抗her2ポリペプチド及びそれらの使用の方法
PCT/US2019/047728 WO2020041604A1 (en) 2018-08-22 2019-08-22 Anti-her2 polypeptides and methods of use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021510094A Division JP2021534220A (ja) 2018-08-22 2019-08-22 抗her2ポリペプチド及びそれらの使用の方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026018549A Division JP2026086616A (ja) 2018-08-22 2026-02-06 抗her2ポリペプチド及びそれらの使用の方法

Publications (3)

Publication Number Publication Date
JP2024150674A JP2024150674A (ja) 2024-10-23
JP2024150674A5 true JP2024150674A5 (cg-RX-API-DMAC7.html) 2025-04-11
JP7818042B2 JP7818042B2 (ja) 2026-02-19

Family

ID=67989062

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021510094A Pending JP2021534220A (ja) 2018-08-22 2019-08-22 抗her2ポリペプチド及びそれらの使用の方法
JP2024119250A Active JP7818042B2 (ja) 2018-08-22 2024-07-25 抗her2ポリペプチド及びそれらの使用の方法
JP2026018549A Pending JP2026086616A (ja) 2018-08-22 2026-02-06 抗her2ポリペプチド及びそれらの使用の方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021510094A Pending JP2021534220A (ja) 2018-08-22 2019-08-22 抗her2ポリペプチド及びそれらの使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026018549A Pending JP2026086616A (ja) 2018-08-22 2026-02-06 抗her2ポリペプチド及びそれらの使用の方法

Country Status (15)

Country Link
US (1) US20220002436A1 (cg-RX-API-DMAC7.html)
EP (1) EP3840781A1 (cg-RX-API-DMAC7.html)
JP (3) JP2021534220A (cg-RX-API-DMAC7.html)
KR (1) KR20210074279A (cg-RX-API-DMAC7.html)
CN (1) CN113286610A (cg-RX-API-DMAC7.html)
AR (1) AR115998A1 (cg-RX-API-DMAC7.html)
AU (2) AU2019326545A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021002953A2 (cg-RX-API-DMAC7.html)
CA (1) CA3141815A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190603A1 (cg-RX-API-DMAC7.html)
IL (2) IL326298A (cg-RX-API-DMAC7.html)
MX (1) MX2021001976A (cg-RX-API-DMAC7.html)
SG (1) SG11202101436SA (cg-RX-API-DMAC7.html)
TW (1) TW202017947A (cg-RX-API-DMAC7.html)
WO (1) WO2020041604A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63818B1 (sr) 2017-02-17 2023-01-31 Denali Therapeutics Inc Konstruisani polipeptidi za vezivanje za receptor transferina
BR112020005271A2 (pt) 2017-10-02 2020-09-15 Denali Therapeutics Inc. proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
JP7543290B2 (ja) 2019-02-20 2024-09-02 デナリ セラピューティクス インコーポレイテッド 抗trem2抗体及びその使用方法
BR112022012230A2 (pt) 2019-12-23 2022-08-30 Denali Therapeutics Inc Variantes de progranulina
US11124567B2 (en) 2020-01-13 2021-09-21 Denali Therapeutics Inc. Anti-TREM2 antibodies and methods of use thereof
CA3170338A1 (en) * 2020-02-19 2021-08-26 Denali Therapeutics Inc. Engineered anti-her2 bispecific proteins
CR20230178A (es) 2020-10-14 2023-07-26 Denali Therapeutics Inc Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas
IL311003A (en) 2021-08-25 2024-04-01 Denali Therapeutics Inc Anti-2HER antibodies and methods of using them
US20240392035A1 (en) * 2021-08-25 2024-11-28 Denali Therapeutics Inc. Engineered anti-her2 bispecific proteins
US20250066449A1 (en) * 2021-12-31 2025-02-27 Imnewrun, Inc. Blood-brain barrier permeable fusion protein and uses thereof
KR20240067001A (ko) * 2022-10-28 2024-05-16 주식회사 아임뉴런 뇌혈관장벽 투과성 융합 단백질 및 이의 용도
JP2025540336A (ja) * 2022-12-08 2025-12-11 アデル,インク 抗タウ抗体及びペプチドを含む融合体とその用途
CN120648654A (zh) * 2024-03-13 2025-09-16 深圳太力生物技术有限责任公司 重组细胞的制备方法、重组细胞及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE423140T1 (de) * 2005-01-05 2009-03-15 F Star Biotech Forsch & Entw Synthetische immunoglobulindomänen mit in regionen des moleküls, die sich von den die komplementarität bestimmenden bereichen unterscheiden, modifizierten bindeeigenschaften
MX367126B (es) * 2012-08-29 2019-08-06 Hoffmann La Roche Transporte para atravesar la barrera hematoencefálica.
WO2014089209A2 (en) * 2012-12-04 2014-06-12 Abbvie, Inc. Blood-brain barrier (bbb) penetrating dual specific binding proteins
WO2015191934A2 (en) * 2014-06-11 2015-12-17 Abbvie Inc. Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
JP7021955B2 (ja) * 2015-06-24 2022-03-03 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト Her2及び血液脳関門受容体に特異的な三重特異性抗体及び使用方法
CN107446045A (zh) * 2016-07-22 2017-12-08 北京天广实生物技术股份有限公司 一种抗her2的抗体、其药物组合物及用途
RS63818B1 (sr) * 2017-02-17 2023-01-31 Denali Therapeutics Inc Konstruisani polipeptidi za vezivanje za receptor transferina
CA3053379A1 (en) * 2017-02-17 2018-08-23 Denali Therapeutics Inc. Anti-tau antibodies and methods of use thereof
WO2019032955A1 (en) * 2017-08-10 2019-02-14 Denali Therapeutics Inc. MODIFIED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES

Similar Documents

Publication Publication Date Title
JP2021534220A5 (cg-RX-API-DMAC7.html)
JP2021533779A5 (cg-RX-API-DMAC7.html)
US11325982B2 (en) Biparatopic and multiparatopic antibodies with common light chain and method of use
JP2020196744A5 (cg-RX-API-DMAC7.html)
US8871912B2 (en) Engineered heterodimeric protein domains
JP2022551969A5 (cg-RX-API-DMAC7.html)
RU2015145719A (ru) Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения
CN106164095A (zh) 多特异性抗体
AU2018387829B2 (en) Bispecific antigen binding construct
JP2021521781A5 (cg-RX-API-DMAC7.html)
US20230192887A1 (en) Engineered anti-her2 bispecific proteins
US20220119549A1 (en) Shielded biologics with masking domains to shield antigen binding capability of biologics and uses thereof
JP2022521305A (ja) 抗pd-l1抗体及びその使用
JPWO2022102768A5 (cg-RX-API-DMAC7.html)
US12486321B2 (en) Agents that interfere with IL-1BETA receptor signalling
IL318098A (en) IGE-FCER pushers
CN119546637A (zh) 与FCγ受体的结合降低的嵌合重链恒定结构域及其用途
CA3229542A1 (en) Anti-her2 antibodies and methods of use thereof
JP2024534118A5 (cg-RX-API-DMAC7.html)
JP2021510162A5 (cg-RX-API-DMAC7.html)
US20260055171A1 (en) Vegf antagonists and methods of use thereof
US20240287162A1 (en) Multivalent anti-spike protein binding molecules and uses thereof
US20240309072A1 (en) Multivalent anti-spike protein binding molecules and uses thereof
JP2025516631A5 (cg-RX-API-DMAC7.html)
JP2025511000A5 (cg-RX-API-DMAC7.html)